Correlation Between Lineage Cell and Coherus BioSciences

Can any of the company-specific risk be diversified away by investing in both Lineage Cell and Coherus BioSciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lineage Cell and Coherus BioSciences into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Lineage Cell Therapeutics and Coherus BioSciences, you can compare the effects of market volatilities on Lineage Cell and Coherus BioSciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lineage Cell with a short position of Coherus BioSciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lineage Cell and Coherus BioSciences.

Diversification Opportunities for Lineage Cell and Coherus BioSciences

0.11

Correlation Coefficient

Lineage Cell  Coherus BioSciences

Average diversification

The 3 months correlation between Lineage and Coherus is 0.11. Overlapping area represents the amount of risk that can be diversified away by holding Lineage Cell Therapeutics and Coherus BioSciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Coherus BioSciences and Lineage Cell is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lineage Cell Therapeutics are associated (or correlated) with Coherus BioSciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Coherus BioSciences has no effect on the direction of Lineage Cell i.e., Lineage Cell and Coherus BioSciences go up and down completely randomly.

Pair Corralation between Lineage Cell and Coherus BioSciences

Given the investment horizon of 90 days Lineage Cell Therapeutics is expected to generate 0.99 times more return on investment than Coherus BioSciences. However, Lineage Cell Therapeutics is 1.01 times less risky than Coherus BioSciences. It trades about 0.02 of its potential returns per unit of risk. Coherus BioSciences is currently generating about -0.15 per unit of risk. If you would invest  50.00  in Lineage Cell Therapeutics on December 29, 2024 and sell it today you would lose (1.00) from holding Lineage Cell Therapeutics or give up 2.0% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Lineage Cell Therapeutics  vs.  Coherus BioSciences

Lineage Cell Therapeutics

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Lineage Cell Therapeutics are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Lineage Cell may actually be approaching a critical reversion point that can send shares even higher in April 2025.

Coherus BioSciences

Risk-Adjusted Performance

Very Weak

Over the last 90 days Coherus BioSciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in April 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Pair Trading with Lineage Cell and Coherus BioSciences

The main advantage of trading using opposite Lineage Cell and Coherus BioSciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lineage Cell position performs unexpectedly, Coherus BioSciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Coherus BioSciences will offset losses from the drop in Coherus BioSciences' long position.

The idea behind Lineage Cell Therapeutics and Coherus BioSciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.